doi: 10.3389/fmed.2025.1526090 Received 11 November 2024 Accepted 30 January 2025 Published 14 February 2025 Volume 12 - 2025 Edited by Anil Kumar Pasupulati, University of Hyderabad, India Reviewed by Nasar Alwahaibi, Sultan Qaboos University, Oman Pedro Paulo Scariot, Sao Francisco University, Brazil Updates Copyright 2025 Boima, Agyekum, Ganatra, Agyekum, Kwakyi, Inusah, Ametefe and Adu
For now, understand that bacteriostatic water for peptides is the standard for multi-dose vials because the benzyl alcohol preservative prevents bacterial growth between uses
Given its long-standing leadership in the GLP-1 market, Novo Nordisk should be able to capitalize on the increased demand for these medicines over the medium term
Current FDA product with smaller daily volume
Also, a greater proportion of participants treated with Zepbound achieved remission or mild sleep apnea with resolution of symptoms compared to placebo
In vivo studies showed that GLP-1RA encourages reduced food consumption and consequent weight reduction by stimulating brown fat and enhancing energy outlay through the action of the sympathetic nervous system (SNS) pathways
